StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)

Close on Nov 17, 2026Market cap $251.95MP/E –Yield –

ClearPoint Neuro price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ClearPoint Neuro's price to book ratio was 26.0× on Nov 11, 2026, against 25.9× a year earlier. Over the last 5 years it ranged from 4.2× to 42.9×, with a median of 7.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202626.0×+1.5
2025Dec 31, 202524.5×+9.9
2024Dec 31, 202414.6×+7.7
2023Dec 29, 20236.9×+1.7
2022Dec 30, 20225.2×−0.6
2021Dec 31, 20215.8×−75.3
2020Oct 30, 202081.1×+69.1
2019Dec 31, 201912.0×+5.0
2018Dec 31, 20186.9×+3.0
2017Dec 29, 20173.9×−17.5
2016Dec 30, 201621.4×–

More ClearPoint Neuro figures

See a number that looks wrong?